About the Product

Description


Ceforom 250 Injection contains Cefpirome 250 mg, a fourth-generation cephalosporin antibiotic used for the treatment of a broad spectrum of bacterial infections caused by susceptible microorganisms. It helps in eliminating infection-causing bacteria by interfering with bacterial cell wall synthesis, thereby preventing bacterial growth and multiplication. The injection is commonly utilized in hospitals and healthcare facilities where prompt and effective antibacterial therapy is required.

Cefpirome offers broad-spectrum antibacterial coverage against a variety of gram-positive and gram-negative pathogens. It is frequently prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, septicemia, and other serious bacterial conditions. Its advanced cephalosporin profile enables it to provide reliable antibacterial activity in cases where broad coverage is clinically required.

The injectable formulation ensures rapid delivery of the medication into the systemic circulation, making it particularly useful in moderate to severe infections requiring immediate treatment. Cefpirome has been extensively used in hospital-based infection management protocols and is valued for its effectiveness against a wide range of susceptible bacterial organisms. The product plays an important role in supporting physicians in the management of complicated infectious diseases.

With the increasing need for advanced injectable antibiotics in healthcare institutions, Ceforom 250 Injection offers significant market potential in the anti-infective segment. Its broad-spectrum efficacy, strong clinical acceptance, and growing demand in hospital settings make it a valuable product for retailers and distributors looking to expand their portfolio in the antibiotic therapy market.


Ceforom 250 Injection is generally well tolerated when administered as directed. Some patients may experience injection site pain, redness, swelling, nausea, vomiting, diarrhea, abdominal discomfort, headache, skin rash, itching, or allergic reactions. Rarely, severe hypersensitivity reactions or alterations in laboratory parameters may occur.

Ceforom 250 Injection is indicated for the treatment of susceptible bacterial infections including respiratory tract infections, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, septicemia, gynecological infections, and other serious bacterial infections. It helps in controlling bacterial growth and reducing infection-related complications.

This medication should be administered only under the supervision of a qualified healthcare professional. The complete prescribed course should be followed to achieve optimal treatment outcomes and help reduce antibiotic resistance. Patients with a history of allergy to cephalosporins, penicillins, or other beta-lactam antibiotics should inform their physician before treatment. Antibiotics should only be used for confirmed or suspected bacterial infections.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the vial in its original packaging until use and out of reach of children. Do not use after the expiry date or if the packaging is damaged, opened, or shows signs of deterioration.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions